Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Growth Disorders × pasireotide × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 2 Gastro-enteropancreatic neuroendocrine tumor 2 Acromegaly 2 Pancreatic Neoplasms 1 Lymphoma, Follicular 1 Growth Disorders 1 Gigantism 1 Carcinoid Tumor 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02354508 2019-12-10

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

Novartis

Phase 3 Completed

123 enrolled 27 charts

Acromegaly, Gigantism, Growth Disorders, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡